| Literature DB >> 35662442 |
Thanh D Hoang1, Derek J Stocker2, Eva L Chou3, Henry B Burch4.
Abstract
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive management plan. A multidisciplinary team is required to manage all aspects of Graves disease, particularly thyroid eye disease, for which new therapeutic options are now available.Entities:
Keywords: Antithyroid drugs; Graves disease; Hyperthyroidism; Radioiodine therapy; Thyroid eye disease; Thyroidectomy
Mesh：
Substances：
Year: 2022 PMID： 35662442 PMCID： PMC9174594 DOI： 10.1016/j.ecl.2021.12.004
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN： 0889-8529 Impact factor: 4.748